Baş, O.; Güdük, N.; Tokatlı, M.; Güven, D.C.; Özer, N.; Şener, Y.Z.; Akın, S.; Aksoy, S.; Barışta, İ.; Türker, F.A.;
et al. Serum Albumin–Creatinine Ratio and Anthracycline Cardiotoxicity in Patients with Cancer. J. Clin. Med. 2025, 14, 1741.
https://doi.org/10.3390/jcm14051741
AMA Style
Baş O, Güdük N, Tokatlı M, Güven DC, Özer N, Şener YZ, Akın S, Aksoy S, Barışta İ, Türker FA,
et al. Serum Albumin–Creatinine Ratio and Anthracycline Cardiotoxicity in Patients with Cancer. Journal of Clinical Medicine. 2025; 14(5):1741.
https://doi.org/10.3390/jcm14051741
Chicago/Turabian Style
Baş, Onur, Naciye Güdük, Mert Tokatlı, Deniz Can Güven, Necla Özer, Yusuf Ziya Şener, Serkan Akın, Sercan Aksoy, İbrahim Barışta, Fatma Alev Türker,
and et al. 2025. "Serum Albumin–Creatinine Ratio and Anthracycline Cardiotoxicity in Patients with Cancer" Journal of Clinical Medicine 14, no. 5: 1741.
https://doi.org/10.3390/jcm14051741
APA Style
Baş, O., Güdük, N., Tokatlı, M., Güven, D. C., Özer, N., Şener, Y. Z., Akın, S., Aksoy, S., Barışta, İ., Türker, F. A., & Dizdar, Ö.
(2025). Serum Albumin–Creatinine Ratio and Anthracycline Cardiotoxicity in Patients with Cancer. Journal of Clinical Medicine, 14(5), 1741.
https://doi.org/10.3390/jcm14051741
